SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001626129-17-000277
Filing Date
2017-04-21
Accepted
2017-04-21 16:21:47
Documents
1
Period of Report
2017-06-07
Effectiveness Date
2017-04-21

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT cgix-def14a_060717.htm DEF 14A 376784
  Complete submission text file 0001626129-17-000277.txt   377935
Mailing Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070
Business Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070 201.528.9200
CANCER GENETICS, INC (Filer) CIK: 0001349929 (see all company filings)

IRS No.: 043462475 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35817 | Film No.: 17776165
SIC: 8071 Services-Medical Laboratories